505 related articles for article (PubMed ID: 18819693)
1. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
[TBL] [Abstract][Full Text] [Related]
2. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
[TBL] [Abstract][Full Text] [Related]
3. Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital.
Durrieu G; Batz A; Rousseau V; Bondon-Guitton E; Petiot D; Montastruc JL
Eur J Clin Pharmacol; 2014 Dec; 70(12):1519-26. PubMed ID: 25304009
[TBL] [Abstract][Full Text] [Related]
4. [Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution].
Couffignal AL; Lapeyre-Mestre M; Bonhomme C; Bugat R; Montastruc JL
Therapie; 2000; 55(5):635-41. PubMed ID: 11201979
[TBL] [Abstract][Full Text] [Related]
5. Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a univeristy hospital in Riyadh.
Al-Malaq HM; Al-Aqeel SA; Al-Sultan MS
Saudi Med J; 2008 Aug; 29(8):1145-50. PubMed ID: 18690308
[TBL] [Abstract][Full Text] [Related]
6. Reporting adverse drug reactions on a geriatric ward: a pilot project.
Somers A; Petrovic M; Robays H; Bogaert M
Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
[TBL] [Abstract][Full Text] [Related]
7. [Use of the PMSI for the detection of adverse drug reactions].
Osmont MN; Cuggia M; Polard E; Riou C; Balusson F; Oger E
Therapie; 2013; 68(4):285-95. PubMed ID: 23981266
[TBL] [Abstract][Full Text] [Related]
8. Under-reporting of serious adverse drug reactions in Sweden.
Bäckström M; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
[TBL] [Abstract][Full Text] [Related]
9. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
Olivier P; Montastruc JL
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
[TBL] [Abstract][Full Text] [Related]
11. Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitals.
Osmont MN; Degremont A; Jantzem H; Audouard-Marzin Y; Lalanne S; Carlhant-Kowalski D; Bellissant E; Oger E; Polard E
Br J Clin Pharmacol; 2021 Feb; 87(2):471-482. PubMed ID: 32484575
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
Sommet A; Durrieu G; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
[TBL] [Abstract][Full Text] [Related]
13. System for voluntary reporting of adverse drug reactions in a university hospital.
Vorce-West TE; Barstow L; Butcher B
Am J Hosp Pharm; 1989 Nov; 46(11):2300-3. PubMed ID: 2589347
[TBL] [Abstract][Full Text] [Related]
14. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J
Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
[TBL] [Abstract][Full Text] [Related]
16. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database.
Durrieu G; Olivier P; Bagheri H; Montastruc JL;
Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous reporting of adverse drug reactions by nurses.
Bäckström M; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):647-50. PubMed ID: 12512239
[TBL] [Abstract][Full Text] [Related]
18. Drug related hospital admissions in subspecialities of internal medicine.
Hallas J
Dan Med Bull; 1996 Apr; 43(2):141-55. PubMed ID: 8741207
[TBL] [Abstract][Full Text] [Related]
19. [Organization and results of drug vigilance in France].
Bégaud B; Chaslerie A; Haramburu F
Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
[TBL] [Abstract][Full Text] [Related]
20. Anti-infectives-induced adverse drug reactions in hospitalized patients.
Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N
Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
